Avalon GloboCare Files 8-K

Ticker: ALBT · Form: 8-K · Filed: Nov 18, 2024 · CIK: 1630212

Sentiment: neutral

Topics: 8-K, SEC Filing, Disclosure

TL;DR

Avalon GloboCare filed an 8-K, standard reporting, no new news.

AI Summary

Avalon GloboCare Corp. filed an 8-K on November 18, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.

Why It Matters

This 8-K filing indicates that Avalon GloboCare Corp. is fulfilling its reporting obligations with the SEC, but it does not disclose any new material information or events.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any specific new risks or material events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Avalon GloboCare Corp.?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.

On what date was this 8-K report filed?

This 8-K report was filed on November 18, 2024.

In which U.S. state is Avalon GloboCare Corp. incorporated?

Avalon GloboCare Corp. is incorporated in Delaware.

What is the SEC file number for Avalon GloboCare Corp.?

The SEC file number for Avalon GloboCare Corp. is 001-38728.

What is the business address of Avalon GloboCare Corp.?

The business address of Avalon GloboCare Corp. is 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.

Filing Stats: 563 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-11-18 09:00:07

Key Financial Figures

Filing Documents

01. Financial Statement and Exhibits

Item 9.01. Financial Statement and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of the Company dated November 18, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: November 18, 2024 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing